Methallylescaline

The onset takes its time, as befits any relative of mescaline. Sixty to ninety minutes pass before the first effects announce themselves: a gradual warming of the body, a subtle deepening of color in the visual field, and a quiet shift in the texture of thought. The stomach may register mild discomfort during the come-up, but it rarely escalates beyond a passing uneasiness. There is a sense of being gently gathered up by the experience, lifted incrementally rather than pushed. The energy is grounded and patient, rooted in the body rather than buzzing through the nerves.

By the two to three hour mark, the visual landscape has opened into a richly detailed psychedelic panorama. Colors are extraordinarily saturated, with a warmth and depth that recalls the visual character of mescaline while adding its own distinctive emphasis. Warm tones dominate -- deep golds, burnt sienna, rich plums, and the intense green of sunlit foliage. Surfaces develop complex, flowing patterns that spiral and undulate with organic fluidity. The geometry has a botanical quality: vines, petals, branching structures, and radially symmetric forms that feel drawn from the deep grammar of plant life. Visual detail is exceptional at moderate doses, with every texture in the environment seeming to reveal hidden layers of structure and beauty. Closed-eye visuals are immersive, presenting slowly evolving landscapes of color and pattern that respond to music and emotional state.

The headspace is contemplative, spacious, and gently profound. Thoughts unfold with a measured, philosophical quality, often turning toward themes of nature, growth, and interconnection. There is a steadiness to the cognitive state that distinguishes it from the more volatile phenethylamines -- the mind remains anchored even as it explores unfamiliar territory. Emotional warmth is significant, manifesting as a deep, quiet appreciation for existence itself. There is a quality of sacredness to the experience that does not need to be imposed or interpreted -- it simply presents itself as a natural feature of the altered state. Music is profoundly enhanced and feels essential to the experience. The body is comfortable, warm, and heavy in a pleasant way.

The duration is long, typically spanning ten to sixteen hours with a broad, sustained plateau that resists any urgency to resolve. The descent is slow and gentle, with visual effects fading gradually while the emotional warmth persists well into the aftermath. The comedown is remarkably smooth for such a long-acting substance. The afterglow can last a day or more and often includes heightened visual sensitivity, emotional openness, and a deepened connection to the natural world. Methallylescaline delivers the contemplative depth and organic beauty of the mescaline experience in a slightly more accessible form, trading some of the raw power of the parent compound for extended duration and gentle reliability.

Mechanism of Action

Methallylescaline acts as a partial agonist at serotonin 5-HT2A receptors, sharing the primary mechanism of all classical phenethylamine psychedelics. The 4-(2-methylallyloxy) group at C4 provides 5-HT2A binding affinity in a range broadly consistent with other mescaline analogs that improve on the 4-methoxy group through increased lipophilicity.

Comparison to Allylescaline and Mescaline

MAL is structurally closely related to allylescaline — differing only in the addition of a methyl group at the 2-position of the allyl chain (making it a "methallyl" rather than allyl group). This modification:

• Further increases lipophilicity relative to allylescaline
• May alter the geometry of receptor engagement
• Introduces a branch point that could affect metabolic clearance rate and metabolite profile

The active dose range of MAL (40–75 mg) suggests it is somewhat less potent than allylescaline despite the additional methyl group, possibly because the increased steric bulk of the methallyl chain reduces optimal receptor fit.

Duration

The 8–12 hour duration is consistent with other extended mescaline analogs. The branched chain may slow metabolic clearance compared to the linear allylescaline, contributing to the duration.

Monoamine Transporter Activity

Low monoamine transporter activity is expected based on structural analogy with mescaline and allylescaline, consistent with the predominantly perceptual and emotional rather than stimulant character of the experience.

Development and PiHKAL

Methallylescaline was synthesized by Alexander Shulgin as part of his systematic program of mescaline 4-position modification. The branched-chain allyloxy variant joined allylescaline, proscaline, escaline, and related compounds in Shulgin's exploration of what structural modifications to mescaline's 4-position produced psychedelic activity, and of what qualitative character different substituents conferred.

PiHKAL (1991) documents MAL with synthesis procedures and Shulgin's personal bioassay notes. The compound receives less text than the better-known mescaline analogs, consistent with its lower potency and less distinctive character compared to allylescaline or escaline.

Community Interest

MAL has attracted a modest following among those specifically interested in Shulgin phenethylamines beyond the mainstream 2C compounds. Interest tends to concentrate among users seeking the "mescaline-like" experiential quality — warm, visually organic, emotionally open — without requiring the hundreds of milligrams necessary for natural mescaline preparations.

Legal Status

Methallylescaline is not explicitly scheduled in all jurisdictions but is subject to phenethylamine analogue laws in many countries. Its rare use means its legal status has rarely been directly tested in regulatory proceedings.